Clinical Research Programs at Pacific Shores Medical Group
Click on diagnosis for more information or Call Irene at 562-590-0345 Ext. 266
| ANEMIA | |
| ANTI-NAUSEA | |
| BONE METASTASES* | |
| BREAST CANCER | |
| prevention adjuvant metastatic 1st line metastatic 2nd/3rd line |
|
| COLON AND RECTAL CANCER | |
| adjuvant metastatic 1st line metastatic 2nd/3rd line |
|
| ESOPHAGEAL/STOMACH | |
| HEAD AND NECK | |
| LUNG | |
| LYMPHOMA | |
| MELANOMA | |
| PANCREAS | |
| PROSTATE | |
| SOLID TUMORS | |
| THYROID | |
| * Metastatic | Cancer resulting from the spread of the primary tumor |
| **Adjuvant therapy | Anticancer drugs, hormones, radiation therapy or other medication given after surgery to prevent the cancer from coming back |
| Back to Top | |
| A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of GS-6624 Combined with FOLFIRI as Second Line Treatment for Metastatic KRAS or BRAF Mutant Colorectal Adenocarcinoma that Has Progressed Following a First Line Oxaliplatin- and Fluoropyrimidine-Containing Regimen. | |
| ESOPHAGEAL/STOMACH | |
| A Randomized, Double-Blind, Phase 3 Study of Docetaxel and Ramucirumab versus Docetaxel and Placebo in the Treatment of Stage IV Non-Small Cell Lung Cancer Following Disease Progression after One Prior Platinum Based Therapy | |
| A Randomized Multicenter Study Comparing Pixantrone + Rituximab with Gemcitabine + Rituximab In Patients with Aggressive B-cell Non-Hodgkin Lymphoma Who Have Relapsed after Therapy with CHOP-R or an Equivalent Regimen and are lneligible for Stem Cell Transplant | |
| MULTIPLE MYELOMA | |
| PANCREAS | |
| A Phase 2 Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Efficacy and Safety of GS-6624 Combined with Gemcitabine as First Line Treatment for Metastatic Pancreatic Adenocarcinoma. | |
| A Multicenter, Open-Label, Randomized, Phase II Trial of Adjuvant Dasatinib plus Gemcitabine versus Single-Agent Gemcitabine in Patients with Resected Pancreatic Adenocarcinoma | |
| PROSTATE | |
| Back to Top | |
| SOLID TUMOR | |
| THYROID | |
| * Metastatic | Cancer resulting from the spread of the primary tumor |
| **Adjuvant therapy | Anticancer drugs, hormones, radiation therapy or other medication given after surgery to prevent the cancer from coming back |